http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011522239-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4712 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-324 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5091 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2009-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2011-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2011522239-A |
| titleOfInvention | Means and methods for identifying subjects sensitive to cardiac therapy based on measurements of cardiac troponin, sCD40L and C-reactive protein |
| abstract | The present invention measures cardiac troponin T and adds C-reactive protein (CRP) or sCD40L (soluble CD40 ligand) in samples of subjects with stable coronary heart disease and a history of acute cardiovascular events Relates to a method for identifying subjects susceptible to cardiac therapy based on the measurement of. Furthermore, the present invention predicts the risk of lethal and / or further acute cardiovascular events for a subject with stable coronary heart disease and a history of acute cardiovascular events based on the measurement of the above markers Regarding the method. Kits and devices made to carry out the methods of the present invention are also encompassed by the present invention. [Selection] Figure 1 |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021185371-A |
| priorityDate | 2008-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 456.